On May 18, 2019, a Myeloma Crowd Round Table meeting was held in St Louis, Missouri at the Eric P. Newman Education Center featuring six myeloma experts, including:
Current Drug Treatments for Multiple Myeloma
Dr. Tanya Wildes of Washington University talks about the current drug therapies for myeloma--chemotherapy, IMiDs, proteasome inhibitors, steroids, monoclonal antibodies, and combination therapies. She describes how these treatments are administered and how they act on myeloma cells.
Transplant for Multiple Myeloma
Dr. Amrita Krishnan of the City of Hope Cancer Center discusses the evolution of transplants in myeloma over time. No longer do doctors rely on chronic age to determine if a patient can receive a transplant, but rather physiological age--which focuses on physical health. She also covers new standards for myeloma and steps toward a cure.
A Journey Through the Decades
Dr. Robert Kyle of the Mayo Clinic Rochester describes a history and journey of myeloma starting in the 19th century and how it has changed over the years, from diagnosis, to treatment, to standard of care.
Innovative Technology and Living with Myeloma
Dr. Jim Omel, myeloma patient and advocate, talks about new technology to treat myeloma, including nano particles, light therapy, and a combination therapy with chemo. His late wife inspired him to "plan to live" with myeloma rather than "live to die".
The Future of Multiple Myeloma Treatment
Dr. Ravi Vij of Washington University addresses the future of myeloma treatment--which comes from clinical trials. He claims "the best is yet to come" for future treatment and therapies, including IMiDs, monoclonal antibodies, CAR T cells, and vaccines.
Integrating Newly Approved Myeloma Therapies into the Clinic
Dr. Mark Schroeder of Washington University describes the rapid changes in myeloma treatment paradigms and how we think about sequencing treatments. He aims to help patients understand the difference in their specific myeloma at diagnosis and currently.
Myeloma Expert Panel and Q&A – Morning
Myeloma experts Drs. Wildes, Kyle, Vij, and Krishnan answer patient questions from the audience during the live Q&A discussion panel. Topics covered include:
Myeloma Expert Panel and Q&A – Afternoon
Myeloma experts Drs. Vij, Stockerl Goldstein, and Schroeder answer patient questions from the audience during the live Q&A discussion panel. Topics covered include:
Thanks to our Platinum Sponsor
Thanks to our additional Myeloma Crowd Round Table Sponsors: Takeda Oncology, GSK, Celgene, Karyopharm and Adaptive Biotechnologies
about the author
Myeloma Crowd Editorial Contributor, Nursing student, and cancer advocate.